Deliveries under this order will take place in 2026. This order includes a one-year base period, with two additional option periods for 2027 and 2028.
ClinNEXUS management will be in attendance during “JPM Week” hosting investor meetings and sharing its new corporate presentation- LOS ANGELES, Jan. 08, 2026 (GLOBE NEWSWIRE) -- ClinNEXUS, (or the ...
(Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced the appointment of Mark A. Wilson as Chief Legal ...
International Medical Cannabis Revenue Increases 36%; Canadian Adult-Use Cannabis Revenue Grows 6%. Tilray Pharma Achieves Record Quarterly Revenue. U.S. Federal Cannabis Reschedu ...
Tuesday, January 13, 2026 Time: 11:30am PT, 2:30pm ET Registration and Webcast: Click Here The webcast will be available on the Company’s investor relations website at for 30 days following the ...
AID system compatible with Senseonics Eversense® 365 one-year CGM. GERMANTOWN, Md., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDA ...
44th Annual J.P. Morgan Healthcare Conference Format: Company presentation Date: Thursday, January 15, 2026 Time: 12:00 PM PT Location: California East at The Westin St. Francis ...
Lightning technology expands upon Treace’s market-leading Lapiplasty ® System with advanced new instrumentation designed to reduce surgical steps, precisely correct in all three planes, and further ...
SOUTH JORDAN, Utah, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that its Board of Directors unanimously ...
This milestone of surpassing 20,000 verifications represents a doubling in just about two months since reaching 10,000 cases on October 23, 2025. We believe this is the result of the synergistic ...
IRVINE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its preliminary, ...
PORTLAND, Maine, Jan. 08, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that develops, manufactures and markets products that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results